Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jessica Maxey
Institution:
Parker Institute for Cancer Immunotherapy
Observed institution:
Parker Institute for Cancer Immunotherapy
ORCID:
0009-0002-4931-6519
Observed ORCID:
0009-0002-4931-6519
OpenAlex ID:
A5043977568
Cellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti–CTLA-4 in Melanoma with Primary Resistance to Anti–PD-1
2026
·
Katie M. Campbell
, Daniel G. Chen
, et al.
·
Cancer Discovery
·
1
Supplementary Figure S1 from Cellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti–CTLA-4 in Melanoma with Primary Resistance to Anti–PD-1
2026
·
Katie M. Campbell
, Daniel G. Chen
, et al.
Supplementary Figure S2 from Cellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti–CTLA-4 in Melanoma with Primary Resistance to Anti–PD-1
2026
·
Katie M. Campbell
, Daniel G. Chen
, et al.
Supplementary Methods 1 from Cellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti–CTLA-4 in Melanoma with Primary Resistance to Anti–PD-1
2026
·
Katie M. Campbell
, Daniel G. Chen
, et al.
Supplementary Figure S4 from Cellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti–CTLA-4 in Melanoma with Primary Resistance to Anti–PD-1
2026
·
Katie M. Campbell
, Daniel G. Chen
, et al.
Supplementary Figure S5 from Cellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti–CTLA-4 in Melanoma with Primary Resistance to Anti–PD-1
2026
·
Katie M. Campbell
, Daniel G. Chen
, et al.
Supplementary Figure S7 from Cellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti–CTLA-4 in Melanoma with Primary Resistance to Anti–PD-1
2026
·
Katie M. Campbell
, Daniel G. Chen
, et al.
Data from Cellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti–CTLA-4 in Melanoma with Primary Resistance to Anti–PD-1
2026
·
Katie M. Campbell
, Daniel G. Chen
, et al.
Supplementary Figure S6 from Cellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti–CTLA-4 in Melanoma with Primary Resistance to Anti–PD-1
2026
·
Katie M. Campbell
, Daniel G. Chen
, et al.
Supplementary Tables S1-S9 from Cellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti–CTLA-4 in Melanoma with Primary Resistance to Anti–PD-1
2026
·
Katie M. Campbell
, Daniel G. Chen
, et al.
Supplementary Figure S3 from Cellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti–CTLA-4 in Melanoma with Primary Resistance to Anti–PD-1
2026
·
Katie M. Campbell
, Daniel G. Chen
, et al.
Abstract 6550: Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1 refractory melanoma
2024
·
Katie M. Campbell
, Zaid Bustami
, et al.
·
Cancer Research
Abstract 4527: CD8 T cell-melanoma cell interactions in response and resistance to ipilimumab plus nivolumab: Biopsy analysis of SWOG S1616
2023
·
Katie M. Campbell
, Lawrence Kuklinski
, et al.
·
Cancer Research
1292 A reproducible pipeline for analysis of multiplex imaging (MIBI) data with application to uncovering novel features of the tumor-immune microenvironment
2022
·
Jessica Maxey
, Marshall Thompson
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Show more works
View as search
Works count:
14
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type